BIO Announces Gene Editing and Synthetic Biology Programming for 2018 World CongressBristol Herald Courier (press release) (blog)WASHINGTON–(BUSINESS WIRE)–Apr 27, 2018–The Biotechnology Innovation Organization (BIO) today announced programming info… Continue reading
Cancer Therapy AdvisorPhase 1/2 Trial of CAR-T Cell Immunotherapy in Metastatic, Mesothelin-Expressing CancerCancer Therapy AdvisorDescription: For this open-label, single-group assignment phase 1/2 study (ClinicalTrials.gov Identifier: NCT01583686), r… Continue reading
Business Wire (press release)BIO Announces Gene Editing and Synthetic Biology Programming for 2018 World CongressBusiness Wire (press release)WASHINGTON–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) today announced programming infor… Continue reading
Nicklaus talks stem cell treatment with GuptaWTHITV.comWhile he wowed the crowd, as the Golden Bear has been doing for five decades, none of the fans knew that just four days earlier Nicklaus had undergone an experimental stem cell therapy in Munich, … Continue reading
Nicklaus talks stem cell treatment with GuptaWTHITV.comWhile he wowed the crowd, as the Golden Bear has been doing for five decades, none of the fans knew that just four days earlier Nicklaus had undergone an experimental stem cell therapy in Munich, … Continue reading
Science Magazine |
Disgraced surgeon is still publishing on stem cell therapies
Science Magazine Paolo Macchiarini, an Italian surgeon, has been fired from two institutions and faces the retraction of many of his papers after findings of scientific misconduct and ethical lapses in his research—yet this hasn’t prevented him from publishing again … |